Initial management |
Further pharmacologic treatment (dose) |
Mechanism |
Indication |
Evidence |
IBS with predominant constipation (IBS-C) | ||||
– To improve IBS symptoms: Water-soluble fiber (psyllium >12 g daily) – To improve stool consistency, as adjuvant treatment (only as needed): Osmotic laxatives: Polyethylene glycol 17 g/d; magnesium hydroxide 15-30 mL/d |
Linaclotide (145-290 microg/d) and plecanatide (3-6 mg/d) |
Guanylate C agonist |
Pain, discomfort, stool consistency, straining |
H |
Lubiprostone (8-24 microg bid) |
Chloride channel activator |
Bloating, pain, straining, frequency, consistency |
M | |
Antispasmodics: Dicyclomine (20-40 mg qid), pinaverium (50-100 mg tid), trimebutine (200 mg tid) |
Anticholinergic or calcium channel blocker |
Pain; may worsen constipation |
VL | |
Antidepressants: Citalopram (20 mg/d), fluoxetine (20 mg/d), paroxetine (20-40 mg/d) |
SSRIs |
Pain, depression |
M | |
IBS with predominant diarrhea (IBS-D) | ||||
Low FODMAP diet for 4-8 weeks |
Loperamide (2-4 mg; max, 12 mg/d; only as needed, not continuously) |
Mu-opioid receptor agonist |
Diarrhea (no effect on pain) as rescue medication |
VL |
Eluxadoline (75-100 mg bid) |
Mixed mu-opioid, delta-opioid, and kappa-opioid receptor agonist |
Diarrhea, pain |
M | |
Diphenoxylate/atropinea: Diphenoxylate 5 mg, then 2.5 mg after each loose bowel movement (max, 20 mg/d) |
Mu-opioid receptor agonist and anticholinergic |
Diarrhea, pain |
M | |
Rifaximin (550 mg tid for 14 days) |
Antimicrobial |
Diarrhea, pain |
M | |
Antidepressants (see IBS-C): Amitriptyline (10-20 mg/d), desipramine (25 mg/d), imipramine (25 mg/d) |
TCAs |
Diarrhea, pain, constipation |
H | |
IBS with mixed bowel habits (IBS-M) | ||||
To improve stool consistency: − Water-soluble fiber (psyllium >12 g daily) − Low FODMAP diet (also improves bloating) − Stop laxatives |
See IBS-D and IBS-C |
See IBS-D and IBS-C |
See IBS-D and IBS-C |
See IBS-D and IBS-C |
Bloating | ||||
Low FODMAP diet |
IBS-C: Linaclotide and lubiprostone |
See IBS-C |
See IBS-D and IBS-C |
See IBS-D and IBS-C |
IBS-D: Rifaximin and eluxadoline |
See IBS-D |
See IBS-D and IBS-C |
See IBS-D and IBS-C | |
a In North America available under trade name Lomotil. | ||||
bid, 2 times a day; FODMAP, fermentable oligosaccharides, disaccharides, monosaccharides, and polyols; IBS, irritable bowel syndrome; H, high quality; M, moderate quality; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant; tid, 3 times a day; VL, very low quality. |